Cargando…
Correction to: Biomarkers and neuromodulation techniques in substance use disorders
Autores principales: | Habelt, Bettina, Arvaneh, Mahnaz, Bernhardt, Nadine, Minev, Ivan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098233/ https://www.ncbi.nlm.nih.gov/pubmed/32232223 http://dx.doi.org/10.1186/s42234-020-00043-7 |
Ejemplares similares
-
Biomarkers and neuromodulation techniques in substance use disorders
por: Habelt, Bettina, et al.
Publicado: (2020) -
A Multimodal Neuroprosthetic Interface to Record, Modulate and Classify Electrophysiological Biomarkers Relevant to Neuropsychiatric Disorders
por: Habelt, Bettina, et al.
Publicado: (2021) -
Correction: The Dopamine Metabolite 3-Methoxytyramine Is a Neuromodulator
por: Sotnikova, Tatyana D., et al.
Publicado: (2010) -
Correction to: Emergency department screening and interventions for substance use disorders
por: Hawk, Kathryn, et al.
Publicado: (2019) -
Correction: The role of substance P in epilepsy and seizure disorders
por: Wang, Xue Feng, et al.
Publicado: (2019)